Features

Features

Adapting to funding and operational hurdles in today’s clinical trials landscape

Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries,…

Irena Maragkou and Frankie Fattorini

Features

EHDS regulation will depend on strong patient confidence

Features

Developing resilient strategies to overcome challenges in clinical research in Europe

Features

Policy changes and digital strategies guide oncology research

Awards

Introducing the Clinical Trials Arena Excellence Awards 2025

Features

Psychedelic drug developers redesign trials to avoid Lykos faux pas

Features

Patient-centric trials: progress but gaps remain

Features

Power of collaboration more pertinent than ever says pharma experts

Features

Pharma’s AI prospects get nudged into the future with EU’s AI act

Features

Are regulators keeping pace with AI adoption in clinical trials?

Features

How can pharma manage rising trial costs?

Features

Can AI replace medical writers? Experts say not immediately

Frankie Fattorini

Features

WHO releases Lancet papers that delve further into clinical trial guidance

Features

Sigrid’s Carb Fence tech targets patients being left behind by GLP1s

Joshua Silverwood

Features

Duchenne muscular dystrophy: Five trials to watch

Joshua Silverwood

Features

Rising Sirturo resistance highlights urgent need for new TB therapies

Features

Funding drought: how can biotech and biopharma keep trials running?

Features

Amid deglobalising trade, experts seek AI safeguards for clinical trial supply

Frankie Fattorini

Features

Are European biopharma manufacturers ‘nearshoring’?

Frankie Fattorini

Features

Inborn errors of metabolism elicit unique challenges for therapy development

Features

NeOnc: bypassing the blood-brain barrier in brain cancer

Joshua Silverwood

Features

OCT West Coast 2025: Recruitment and regulation remain pain points

Features

Podcast: How Trump’s tariffs will impact clinical trials

Features

Trump’s tariffs will trickle down the clinical trial chain

Features

OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key

Features

The AI advantage in discovering new medicines

Excellence Awards

Clinical Trials Arena Excellence Awards 2024 – Winners Announced!

Features

The biggest challenges clinical trials will face in 2025

Features

Most significant clinical trials of 2024

Features

CTO Europe 2024: keep the burden of trials away from patients, say experts

Joshua Silverwood

Features

ADCs breach barriers to become mainstream cancer treatment

Natasha Spencer-Jolliffe

Features

WHO trial guidance goes beyond race and gender when tackling diversity

Features

Experts call for a shift from reactive to proactive clinical trial supply frameworks

Features

US reproductive laws could limit women’s participation in clinical trials

Phalguni Deswal

Features

Does Southeast Asia have a growing role in vaccine development?

Features

Prostate cancer: Three drug trials to watch

Features

How decentralisation can fill the gaps in Alzheimer’s research

Jenna Philpott and Irena Maragkou

Features

Preparing for DSCSA transition with tech-led compliance

Natasha Spencer-Jolliffe

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close